Human blood late outgrowth endothelial cells for gene therapy of cancer: determinants of efficacy

[1]  M. Weller,et al.  Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-β-dependent HIF-1α-mediated induction of CXCL12 , 2006 .

[2]  R. Jain,et al.  Evidence for bone marrow-derived endothelial cells incorporation into perfused blood vessels in tumors , 2006 .

[3]  R. Jain,et al.  Evidence for incorporation of bone marrow-derived endothelial cells into perfused blood vessels in tumors. , 2006, Blood.

[4]  Victor Frenkel,et al.  Magnetic Resonance Imaging and Confocal Microscopy Studies of Magnetically Labeled Endothelial Progenitor Cells Trafficking to Sites of Tumor Angiogenesis , 2006, Stem cells.

[5]  R. Mansel,et al.  Expression of Placenta growth factor (PlGF) in non-Small cell Lung cancer (NSCLC) and the clinical and prognostic significance , 2005, World journal of surgical oncology.

[6]  M. Shikami,et al.  Placenta growth factor stimulates the growth of Philadelphia chromosome positive acute lymphoblastic leukemia cells by both autocrine and paracrine pathways , 2005, European journal of haematology.

[7]  S. Rafii,et al.  Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9–mediated progenitor cell mobilization , 2005, The Journal of experimental medicine.

[8]  A. Karsan,et al.  Minimal Contribution of Marrow-Derived Endothelial Precursors to Tumor Vasculature1 , 2005, The Journal of Immunology.

[9]  Luigi Naldini,et al.  Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. , 2005, Cancer cell.

[10]  F. Hsieh,et al.  Placenta growth factor expression is correlated with survival of patients with colorectal cancer , 2005, Gut.

[11]  R. Weissleder,et al.  Bone marrow-derived lin(-)c-kit(+)Sca-1+ stem cells do not contribute to vasculogenesis in Lewis lung carcinoma. , 2005, Neoplasia.

[12]  B. Peters,et al.  Contribution of bone marrow–derived endothelial cells to human tumor vasculature , 2005, Nature Medicine.

[13]  L. Ellis,et al.  Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  H. Kubo,et al.  Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells. , 2004, Biochemical and biophysical research communications.

[15]  D. Wolf,et al.  Endothelial progenitor cells: A source for therapeutic vasculogenesis? , 2004, Journal of cellular and molecular medicine.

[16]  B. Fingleton,et al.  Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. , 2004, Cancer cell.

[17]  K. Alitalo,et al.  Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. , 2004, Blood.

[18]  King-Jen Chang,et al.  The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer. , 2004, Cancer letters.

[19]  Mark A. Hall,et al.  Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. , 2004, Blood.

[20]  W. Gerald,et al.  Utilization of Bone Marrow-Derived Endothelial Cell Precursors in Spontaneous Prostate Tumors Varies with Tumor Grade , 2004, Cancer Research.

[21]  T. Schmid,et al.  CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer , 2004, Journal of Clinical Pathology.

[22]  R. Vile,et al.  Use of blood outgrowth endothelial cells as virus-producing vectors for gene delivery to tumors. , 2004, American journal of physiology. Heart and circulatory physiology.

[23]  A. Marx,et al.  Thymic carcinoma with overexpression of mutated KIT and the response to imatinib. , 2004, The New England journal of medicine.

[24]  X. Moore,et al.  Endothelial progenitor cells’ ‘homing’ specificity to brain tumors , 2004, Gene Therapy.

[25]  G. Tobelem,et al.  Ex vivo differentiated endothelial and smooth muscle cells from human cord blood progenitors home to the angiogenic tumor vasculature. , 2004, Cardiovascular research.

[26]  H. Yamanaka,et al.  Prognostic significance of plasma placental growth factor levels in renal cell cancer: an association with clinical characteristics and vascular endothelial growth factor levels. , 2003, Anticancer research.

[27]  S. Renninger,et al.  Minor Contribution of Bone Marrow‐Derived Endothelial Progenitors to the Vascularization of Murine Gliomas , 2003, Brain pathology.

[28]  W. Gerald,et al.  Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. , 2003, Cancer cell.

[29]  A. Luttun,et al.  Placental growth factor and its receptor, vascular endothelial growth factor receptor‐1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders , 2003, Journal of thrombosis and haemostasis : JTH.

[30]  L. Naldini,et al.  Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells , 2003, Nature Medicine.

[31]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[32]  Zvi Fuks,et al.  Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis , 2003, Science.

[33]  Winfried Brenner,et al.  Assessment of the Tissue Distribution of Transplanted Human Endothelial Progenitor Cells by Radioactive Labeling , 2003, Circulation.

[34]  H. Fine,et al.  Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectors , 2003, Gene Therapy.

[35]  Jean-Luc Balligand,et al.  Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy. , 2003, Cancer research.

[36]  Wadih Arap,et al.  Probing the structural and molecular diversity of tumor vasculature. , 2002, Trends in molecular medicine.

[37]  S. Rafii,et al.  Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.

[38]  L. Benjamin,et al.  Placental growth factor is a survival factor for tumor endothelial cells and macrophages. , 2002, Cancer research.

[39]  Alice P. Taylor,et al.  Tumor-specific regulation of angiogenic growth factors and their receptors during recovery from cytotoxic therapy. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[40]  Liming Chang,et al.  Use of blood outgrowth endothelial cells for gene therapy for hemophilia A. , 2002, Blood.

[41]  S. Rafii,et al.  Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth , 2001, Nature Medicine.

[42]  A. Nienhuis,et al.  Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[43]  Till Acker,et al.  Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions , 2001, Nature Medicine.

[44]  T. Noda,et al.  Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis. , 2001, Cancer research.

[45]  S. Rafii,et al.  Vascular Trauma Induces Rapid but Transient Mobilization of VEGFR2+AC133+ Endothelial Precursor Cells , 2001 .

[46]  P. Lacal,et al.  Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor. , 2000, The Journal of investigative dermatology.

[47]  D. Curiel,et al.  Genetically modified CD34+ cells exert a cytotoxic bystander effect on human endothelial and cancer cells. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[48]  D. Hanahan,et al.  MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.

[49]  P. Leroy,et al.  In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene. , 2000, Cancer research.

[50]  K. Plate,et al.  Expression and localization of placenta growth factor and PlGF receptors in human meningiomas , 1999, The Journal of pathology.

[51]  J. Isner,et al.  Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. , 1999, Circulation research.

[52]  J. Isner,et al.  VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.

[53]  R. Weichselbaum,et al.  Blockade of the Vascular Endothelial Growth Factor Stress Response Increases the Antitumor Effects of Ionizing Radiation , 1999 .

[54]  G. Breier,et al.  The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities , 1996, The Journal of Biological Chemistry.

[55]  C. Richards,et al.  Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[56]  P. Angelberger,et al.  Indium-111-labeled low-density lipoprotein binds with higher affinity to the human liver as compared to iodine-123-low-density-labeled lipoprotein. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[57]  M. Weller,et al.  Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12. , 2006, Brain : a journal of neurology.

[58]  H. Fine,et al.  Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. , 2005, Blood.

[59]  A. Luttun,et al.  Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 , 2002, Nature Medicine.

[60]  R. Hebbel,et al.  Origins of circulating endothelial cells and endothelial outgrowth from blood. , 2000, The Journal of clinical investigation.

[61]  R. Weichselbaum,et al.  Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. , 1999, Cancer research.